トヨタプリウス ポータブルナビ ETC取り付け
2014年02月21日
工場の鈴木です
本日は
プリウスニ
ポータブルナビと
ETCを取り付けました
当店では電源裏取りできます
車検、点検、整備も レストガレージ へ
えっちーのRG WORKSブログ携帯版はこちら
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
この記事へのコメント
(Ina)
beginner dianabol cycle
https://urlscan.io/result/0199c3ab-223e-7769-a6cf-4ca938306b32/ https://urlscan.io
https://molchanovonews.ru/user/dogsnail8/ molchanovonews.ru
https://maps.google.cat/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://maps.google.cat/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect
https://images.google.ms/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://images.google.ms
https://www.google.com.uy/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect www.google.com.uy
http://www.annunciogratis.net/author/tunegrass44 annunciogratis.net
https://proxyrate.ru/user/sushiaries2/ proxyrate.ru
https://skitterphoto.com/photographers/1600835/hanley-bauer https://skitterphoto.com/photographers/1600835/hanley-bauer
https://rentry.co/7boxep88 rentry.co
https://autovin-info.com/user/plowsampan43/ autovin-info.com
https://xn----7sbarohhk4a0dxb3c.xn--p1ai/user/harpskill13/ --7sbarohhk4a0dxb3c.рф
https://motionentrance.edu.np/profile/rainrandom61/ motionentrance.edu.np
http://09vodostok.ru/user/wishbacon64/ http://09vodostok.ru/
https://www.google.bs/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://www.google.bs/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect
https://images.google.com.sv/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://images.google.com.sv
https://xn---6-jlc6c.xn--p1ai/user/sleepbutane10/ https://-6-jlc6c.рф/user/sleepbutane10/
https://firsturl.de/bhFgkZC https://firsturl.de/
https://molchanovonews.ru/user/bathlayer20/ https://molchanovonews.ru/user/bathlayer20
https://urlscan.io/result/0199c3ab-223e-7769-a6cf-4ca938306b32/ https://urlscan.io
https://molchanovonews.ru/user/dogsnail8/ molchanovonews.ru
https://maps.google.cat/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://maps.google.cat/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect
https://images.google.ms/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://images.google.ms
https://www.google.com.uy/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect www.google.com.uy
http://www.annunciogratis.net/author/tunegrass44 annunciogratis.net
https://proxyrate.ru/user/sushiaries2/ proxyrate.ru
https://skitterphoto.com/photographers/1600835/hanley-bauer https://skitterphoto.com/photographers/1600835/hanley-bauer
https://rentry.co/7boxep88 rentry.co
https://autovin-info.com/user/plowsampan43/ autovin-info.com
https://xn----7sbarohhk4a0dxb3c.xn--p1ai/user/harpskill13/ --7sbarohhk4a0dxb3c.рф
https://motionentrance.edu.np/profile/rainrandom61/ motionentrance.edu.np
http://09vodostok.ru/user/wishbacon64/ http://09vodostok.ru/
https://www.google.bs/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://www.google.bs/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect
https://images.google.com.sv/url?q=https://www.valley.md/dianabol-before-and-after-results-you-can-expect https://images.google.com.sv
https://xn---6-jlc6c.xn--p1ai/user/sleepbutane10/ https://-6-jlc6c.рф/user/sleepbutane10/
https://firsturl.de/bhFgkZC https://firsturl.de/
https://molchanovonews.ru/user/bathlayer20/ https://molchanovonews.ru/user/bathlayer20
[2025-10-12 18:39:52.232238]
URL
(Leland)
BPC?157 is a synthetic peptide that has attracted attention for its potential healing properties in both preclinical and anecdotal reports.
Despite this interest, it remains on the radar of regulatory
authorities such as the U.S. Food and Drug Administration (FDA),
which have taken a cautious stance regarding its use.
The following discussion explores why BPC?157 is banned by the FDA, the reasons
behind its continued availability as an oral supplement in certain markets, the benefits that users cite,
and the concerns that drive regulatory scrutiny.
Why is BPC 157 banned by the FDA?
The FDA regulates substances intended for medical treatment or prevention of
disease under the Federal Food, Drug, and Cosmetic Act. For
a compound to be approved as a drug, it must undergo rigorous preclinical
studies, clinical trials in humans, and post?marketing surveillance.
BPC?157 has not completed these steps. It is
considered an unapproved investigational new drug (IND) and therefore cannot be marketed or sold
with claims that it treats, cures, or prevents
any medical condition. The FDA’s ban reflects the lack of sufficient evidence to demonstrate safety, efficacy, consistent manufacturing quality, and appropriate labeling.
Why we still offer BPC?157 as an oral supplement
Although BPC?157 is not approved as a drug, it can be marketed in some jurisdictions as a dietary
supplement if the manufacturer claims that it provides general health benefits rather than specific therapeutic effects.
The FDA’s Dietary Supplement Health and Education Act (DSHEA) allows such products provided they do not contain prohibited ingredients or make disease?specific claims.
In many online markets, BPC?157 is sold in capsule or powder form under
the pretext of supporting joint health, muscle recovery, or
general wellness. This positioning skirts regulatory limits because it avoids
asserting that the product treats a particular medical condition. Consumers can purchase these
supplements without FDA oversight for approval, though the company must still comply
with good manufacturing practices and not make unsubstantiated claims.
Benefits of BPC 157
BPC?157 is a pentadecapeptide derived from a protein found in gastric juice.
In animal studies, it has shown remarkable effects on tissue repair,
including:
Accelerated healing of tendons, ligaments, muscles, and bones.
Reduction of inflammation and oxidative stress at injury sites.
Enhanced angiogenesis (formation of new blood vessels) which aids nutrient delivery to damaged tissues.
Modulation of nerve growth factors that may improve peripheral
nerve regeneration.
Because of these properties, proponents suggest that BPC?157 could help athletes recover faster from sports injuries, aid patients
with chronic tendonitis or ligament tears, and even support gut health by promoting mucosal repair.
FDA’s Concerns
Despite promising laboratory data, the FDA has expressed several concerns:
Lack of human clinical trials: No randomized controlled studies have confirmed safety or efficacy in people.
Potential for off?label claims: Marketing a product as a cure or
treatment for specific injuries may be deceptive and violates FDA regulations.
Unknown long?term effects: The peptide’s impact on hormonal balance, immune function,
or unintended tissue growth is not well understood.
Quality control issues: Supplements sold online vary in purity, dosage accuracy,
and contamination risk.
Interaction with other medications: There is no data on how BPC?157 might interact
with commonly used drugs.
Reported Benefits of BPC 157
Users who report positive outcomes often highlight the following:
Rapid Recovery ? Many athletes claim that injuries such as torn ligaments
or muscle strains heal noticeably faster when using BPC?157 compared to
conventional rest and physiotherapy alone.
Reduced Pain ? Anecdotal accounts describe
a significant decrease in pain scores within days of starting
supplementation, sometimes eliminating the need for NSAIDs.
Improved Flexibility ? Some individuals notice increased joint mobility after consistent use,
which they attribute to connective tissue remodeling.
Gut Healing ? Since BPC?157 originates from gastric peptides, users with inflammatory bowel conditions report symptom relief and improved
digestion.
Enhanced Athletic Performance ? A minority
of users suggest that the peptide improves endurance or reduces muscle fatigue, possibly due to better oxygen delivery through enhanced angiogenesis.
While these reported benefits are compelling for those who have tried the supplement, it is important to remember that
they stem from personal testimonies rather than systematic scientific
evidence. The absence of peer?reviewed clinical trials means that safety margins, optimal dosing, and long?term outcomes remain largely unknown.
In summary, BPC?157 is banned by the FDA as a drug because it has not met the rigorous standards required for medical approval.
Its continued presence on the market as an oral supplement relies on framing it
as a general wellness product rather than a disease treatment.
The peptide’s potential benefits?such as accelerated tissue repair, pain reduction, and
improved gut health?are supported mainly by animal research and user anecdotes.
Regulatory concerns center on safety, efficacy, quality control, and the risk of
misleading claims. Until well?designed human studies are published,
consumers should approach BPC?157 with caution and remain aware that its
legal status reflects unresolved scientific uncertainty.
Despite this interest, it remains on the radar of regulatory
authorities such as the U.S. Food and Drug Administration (FDA),
which have taken a cautious stance regarding its use.
The following discussion explores why BPC?157 is banned by the FDA, the reasons
behind its continued availability as an oral supplement in certain markets, the benefits that users cite,
and the concerns that drive regulatory scrutiny.
Why is BPC 157 banned by the FDA?
The FDA regulates substances intended for medical treatment or prevention of
disease under the Federal Food, Drug, and Cosmetic Act. For
a compound to be approved as a drug, it must undergo rigorous preclinical
studies, clinical trials in humans, and post?marketing surveillance.
BPC?157 has not completed these steps. It is
considered an unapproved investigational new drug (IND) and therefore cannot be marketed or sold
with claims that it treats, cures, or prevents
any medical condition. The FDA’s ban reflects the lack of sufficient evidence to demonstrate safety, efficacy, consistent manufacturing quality, and appropriate labeling.
Why we still offer BPC?157 as an oral supplement
Although BPC?157 is not approved as a drug, it can be marketed in some jurisdictions as a dietary
supplement if the manufacturer claims that it provides general health benefits rather than specific therapeutic effects.
The FDA’s Dietary Supplement Health and Education Act (DSHEA) allows such products provided they do not contain prohibited ingredients or make disease?specific claims.
In many online markets, BPC?157 is sold in capsule or powder form under
the pretext of supporting joint health, muscle recovery, or
general wellness. This positioning skirts regulatory limits because it avoids
asserting that the product treats a particular medical condition. Consumers can purchase these
supplements without FDA oversight for approval, though the company must still comply
with good manufacturing practices and not make unsubstantiated claims.
Benefits of BPC 157
BPC?157 is a pentadecapeptide derived from a protein found in gastric juice.
In animal studies, it has shown remarkable effects on tissue repair,
including:
Accelerated healing of tendons, ligaments, muscles, and bones.
Reduction of inflammation and oxidative stress at injury sites.
Enhanced angiogenesis (formation of new blood vessels) which aids nutrient delivery to damaged tissues.
Modulation of nerve growth factors that may improve peripheral
nerve regeneration.
Because of these properties, proponents suggest that BPC?157 could help athletes recover faster from sports injuries, aid patients
with chronic tendonitis or ligament tears, and even support gut health by promoting mucosal repair.
FDA’s Concerns
Despite promising laboratory data, the FDA has expressed several concerns:
Lack of human clinical trials: No randomized controlled studies have confirmed safety or efficacy in people.
Potential for off?label claims: Marketing a product as a cure or
treatment for specific injuries may be deceptive and violates FDA regulations.
Unknown long?term effects: The peptide’s impact on hormonal balance, immune function,
or unintended tissue growth is not well understood.
Quality control issues: Supplements sold online vary in purity, dosage accuracy,
and contamination risk.
Interaction with other medications: There is no data on how BPC?157 might interact
with commonly used drugs.
Reported Benefits of BPC 157
Users who report positive outcomes often highlight the following:
Rapid Recovery ? Many athletes claim that injuries such as torn ligaments
or muscle strains heal noticeably faster when using BPC?157 compared to
conventional rest and physiotherapy alone.
Reduced Pain ? Anecdotal accounts describe
a significant decrease in pain scores within days of starting
supplementation, sometimes eliminating the need for NSAIDs.
Improved Flexibility ? Some individuals notice increased joint mobility after consistent use,
which they attribute to connective tissue remodeling.
Gut Healing ? Since BPC?157 originates from gastric peptides, users with inflammatory bowel conditions report symptom relief and improved
digestion.
Enhanced Athletic Performance ? A minority
of users suggest that the peptide improves endurance or reduces muscle fatigue, possibly due to better oxygen delivery through enhanced angiogenesis.
While these reported benefits are compelling for those who have tried the supplement, it is important to remember that
they stem from personal testimonies rather than systematic scientific
evidence. The absence of peer?reviewed clinical trials means that safety margins, optimal dosing, and long?term outcomes remain largely unknown.
In summary, BPC?157 is banned by the FDA as a drug because it has not met the rigorous standards required for medical approval.
Its continued presence on the market as an oral supplement relies on framing it
as a general wellness product rather than a disease treatment.
The peptide’s potential benefits?such as accelerated tissue repair, pain reduction, and
improved gut health?are supported mainly by animal research and user anecdotes.
Regulatory concerns center on safety, efficacy, quality control, and the risk of
misleading claims. Until well?designed human studies are published,
consumers should approach BPC?157 with caution and remain aware that its
legal status reflects unresolved scientific uncertainty.
[2025-10-06 20:35:05.102815]
URL
(Houston)
Anavar Cycle Before And After: Transformations And
Results
Short answer
Anabolic?androgenic steroids (AAS) are synthetic compounds derived from the male sex hormone
testosterone. They are designed to maximize muscle growth,
strength and recovery while minimizing the natural side?effects of excess testosterone.
In other words, they’re not just "testosterone" ? they are a family of modified hormones that act
on the same receptors but with different potency, duration, and
tissue selectivity.
Because they interfere with normal hormone balance, AAS can have powerful effects?both beneficial for performance and harmful to health.
That’s why their use is tightly regulated in sports, medicine, and even everyday life.
---
1. What Exactly Are AAS?
Feature Traditional Testosterone Typical AAS
Origin Endogenous steroid from the body Synthetic analogues of testosterone or
dihydrotestosterone (DHT)
Chemical Modifications None Substitutions at positions 2,
3, 17α, etc. to change solubility, resistance to metabolism
Pharmacokinetics Rapidly metabolized by liver; short half?life (~4?5?h orally) Longer half?life, higher lipophilicity →
greater muscle uptake; some are injectable
Metabolism Oxidation at C3, 17α to form inactive metabolites Often more resistant to oxidation; may form active metabolites that
act as aromatase inhibitors or androgen receptor agonists
Biological Activity Low potency (IC?????5?10??M) Higher
affinity for aromatase and AR (IC?????0.1?2??M); some are potent estrogen synthesis blockers
---
4. Why do these drugs become highly active in cancer patients?
Mechanism How it enhances anti?cancer activity
Aromatase inhibition Blocks conversion of androgens → estrogens; reduces tumor growth in ER? breast, ovarian, endometrial
cancers.
Androgen receptor antagonism Directly blocks AR signaling that drives prostate cancer proliferation.
Inhibition of steroidogenic enzymes (CYP17A1, 5α?reductase) Lowers production of androgenic metabolites in the tumor microenvironment; useful for castration?resistant prostate cancer and hormone?dependent breast cancers.
Combination with chemotherapy / targeted therapy Enhances chemosensitivity by reducing survival
signaling mediated through steroid hormones.
Use as endocrine modulators in other diseases (e.g., polycystic
ovary syndrome, adrenal hyperplasia) Modulates excess androgen production that
underlies many endocrine disorders.
---
Key Take?away
Steroid?based drugs are central to the treatment of a wide spectrum
of hormone?dependent cancers and endocrine disorders.
Their effectiveness stems from precise targeting of steroid receptors or modulation of steroid biosynthesis, with therapeutic decisions driven by tumor receptor status, disease stage,
and patient tolerability. Continued research into selective modulators and
combination regimens promises further refinement in efficacy and safety for patients worldwide.
Results
Short answer
Anabolic?androgenic steroids (AAS) are synthetic compounds derived from the male sex hormone
testosterone. They are designed to maximize muscle growth,
strength and recovery while minimizing the natural side?effects of excess testosterone.
In other words, they’re not just "testosterone" ? they are a family of modified hormones that act
on the same receptors but with different potency, duration, and
tissue selectivity.
Because they interfere with normal hormone balance, AAS can have powerful effects?both beneficial for performance and harmful to health.
That’s why their use is tightly regulated in sports, medicine, and even everyday life.
---
1. What Exactly Are AAS?
Feature Traditional Testosterone Typical AAS
Origin Endogenous steroid from the body Synthetic analogues of testosterone or
dihydrotestosterone (DHT)
Chemical Modifications None Substitutions at positions 2,
3, 17α, etc. to change solubility, resistance to metabolism
Pharmacokinetics Rapidly metabolized by liver; short half?life (~4?5?h orally) Longer half?life, higher lipophilicity →
greater muscle uptake; some are injectable
Metabolism Oxidation at C3, 17α to form inactive metabolites Often more resistant to oxidation; may form active metabolites that
act as aromatase inhibitors or androgen receptor agonists
Biological Activity Low potency (IC?????5?10??M) Higher
affinity for aromatase and AR (IC?????0.1?2??M); some are potent estrogen synthesis blockers
---
4. Why do these drugs become highly active in cancer patients?
Mechanism How it enhances anti?cancer activity
Aromatase inhibition Blocks conversion of androgens → estrogens; reduces tumor growth in ER? breast, ovarian, endometrial
cancers.
Androgen receptor antagonism Directly blocks AR signaling that drives prostate cancer proliferation.
Inhibition of steroidogenic enzymes (CYP17A1, 5α?reductase) Lowers production of androgenic metabolites in the tumor microenvironment; useful for castration?resistant prostate cancer and hormone?dependent breast cancers.
Combination with chemotherapy / targeted therapy Enhances chemosensitivity by reducing survival
signaling mediated through steroid hormones.
Use as endocrine modulators in other diseases (e.g., polycystic
ovary syndrome, adrenal hyperplasia) Modulates excess androgen production that
underlies many endocrine disorders.
---
Key Take?away
Steroid?based drugs are central to the treatment of a wide spectrum
of hormone?dependent cancers and endocrine disorders.
Their effectiveness stems from precise targeting of steroid receptors or modulation of steroid biosynthesis, with therapeutic decisions driven by tumor receptor status, disease stage,
and patient tolerability. Continued research into selective modulators and
combination regimens promises further refinement in efficacy and safety for patients worldwide.
[2025-10-01 17:20:04.940691]
URL
(Linda)
Ipamorelin Side Effects Safety And Risks Explained
Ipamorelin Side Effects
Ipamorelin is generally well tolerated, but users
may experience mild adverse reactions such as headaches, flushing,
dizziness, and temporary nausea. In rare cases, more pronounced symptoms can occur, including joint discomfort or increased appetite.
These side effects are usually transient and resolve once
the dosage is adjusted or the treatment period ends.
About Ipamorelin
Ipamorelin is a synthetic peptide that stimulates growth hormone (GH) release.
It belongs to the ghrelin receptor agonist class, mimicking the body’s natural hunger hormone but specifically targeting
the GH secretagogue receptor. The peptide is commonly used by athletes and bodybuilders for its potential benefits in muscle recovery,
fat loss, and improved sleep quality.
Mechanism of Action
Ipamorelin binds to the growth hormone secretagogue receptor (GHS-R1a) located on pituitary
somatotroph cells. This binding triggers a cascade that increases cyclic AMP production,
leading to the secretion of growth hormone into circulation. Unlike other GH stimulators, ipamorelin does not stimulate prolactin or thyroid-stimulating hormone release, which contributes to its favorable safety profile.
Molecular Structure of Ipamorelin
The peptide has the sequence His-Ser-Gln-Asp-Trp-Lys-Pro-Lys-D-Ala-Phe-NH?.
It is a 12?residue amino acid chain that includes
both natural and D-amino acids. The presence of D-alanine at position nine confers resistance
to enzymatic degradation, prolonging its activity in the bloodstream.
Possible Side Effects of Ipamorelin
Headache: Often mild and can be managed with over?the?counter analgesics.
Flushing: A brief reddening of the skin that typically resolves within minutes.
Dizziness or lightness: May occur during initial dosing but usually diminishes as
tolerance develops.
Nausea or gastrointestinal upset: Rare, and often linked to higher dosages.
Patients with pre?existing medical conditions should
consult a healthcare professional before beginning therapy.
Water Retention
A notable effect of increased growth hormone is mild
water retention. Users may notice subtle swelling in extremities or a slight increase
in body weight due to fluid accumulation. This phenomenon generally resolves after the treatment period
ends or if the dose is reduced.
Safety
Clinical trials have shown ipamorelin to be safe when used at recommended doses.
Long?term safety data are limited, so continuous monitoring
for any adverse reactions is advised. The peptide’s selective action on GH release minimizes risks associated with other hormone?stimulating
agents.
More About Ipamorelin Peptide
Beyond its primary use for growth hormone stimulation, ipamorelin has been studied for potential benefits
in tissue repair and anti?aging therapies. Its ability to
promote lean muscle mass while sparing fat tissue makes it attractive for individuals looking to
enhance athletic performance or support recovery after injury.
Ipamorelin - Dosage
Typical dosing ranges from 100??g to 300??g per injection, administered
once daily or split into two doses (morning and evening).
The exact amount depends on the individual’s goals,
body weight, and response. It is important to start at the lower end
of the spectrum, monitor for side effects, and adjust incrementally under professional guidance.
---
Ipamorelin Side Effects
Ipamorelin is generally well tolerated, but users
may experience mild adverse reactions such as headaches, flushing,
dizziness, and temporary nausea. In rare cases, more pronounced symptoms can occur, including joint discomfort or increased appetite.
These side effects are usually transient and resolve once
the dosage is adjusted or the treatment period ends.
About Ipamorelin
Ipamorelin is a synthetic peptide that stimulates growth hormone (GH) release.
It belongs to the ghrelin receptor agonist class, mimicking the body’s natural hunger hormone but specifically targeting
the GH secretagogue receptor. The peptide is commonly used by athletes and bodybuilders for its potential benefits in muscle recovery,
fat loss, and improved sleep quality.
Mechanism of Action
Ipamorelin binds to the growth hormone secretagogue receptor (GHS-R1a) located on pituitary
somatotroph cells. This binding triggers a cascade that increases cyclic AMP production,
leading to the secretion of growth hormone into circulation. Unlike other GH stimulators, ipamorelin does not stimulate prolactin or thyroid-stimulating hormone release, which contributes to its favorable safety profile.
Molecular Structure of Ipamorelin
The peptide has the sequence His-Ser-Gln-Asp-Trp-Lys-Pro-Lys-D-Ala-Phe-NH?.
It is a 12?residue amino acid chain that includes
both natural and D-amino acids. The presence of D-alanine at position nine confers resistance
to enzymatic degradation, prolonging its activity in the bloodstream.
Possible Side Effects of Ipamorelin
Headache: Often mild and can be managed with over?the?counter analgesics.
Flushing: A brief reddening of the skin that typically resolves within minutes.
Dizziness or lightness: May occur during initial dosing but usually diminishes as
tolerance develops.
Nausea or gastrointestinal upset: Rare, and often linked to higher dosages.
Patients with pre?existing medical conditions should
consult a healthcare professional before beginning therapy.
Water Retention
A notable effect of increased growth hormone is mild
water retention. Users may notice subtle swelling in extremities or a slight increase
in body weight due to fluid accumulation. This phenomenon generally resolves after the treatment period
ends or if the dose is reduced.
Safety
Clinical trials have shown ipamorelin to be safe when used at recommended doses.
Long?term safety data are limited, so continuous monitoring
for any adverse reactions is advised. The peptide’s selective action on GH release minimizes risks associated with other hormone?stimulating
agents.
More About Ipamorelin Peptide
Beyond its primary use for growth hormone stimulation, ipamorelin has been studied for potential benefits
in tissue repair and anti?aging therapies. Its ability to
promote lean muscle mass while sparing fat tissue makes it attractive for individuals looking to
enhance athletic performance or support recovery after injury.
Ipamorelin - Dosage
Typical dosing ranges from 100??g to 300??g per injection, administered
once daily or split into two doses (morning and evening).
The exact amount depends on the individual’s goals,
body weight, and response. It is important to start at the lower end
of the spectrum, monitor for side effects, and adjust incrementally under professional guidance.
---
[2025-09-25 17:12:59.401808]
URL